Abstract:[Purpose] To investigate the association of polymorphisms in mTOR(rs2295080) and prognosis of colorectal cancer patients.[Methods] 488 surgically resected colorectal cancer patients were divided into several groups according to their genotypes,in order to explore the links between SNP rs2295080 and the survival of colorectal cancer patients in a Chinese population.[Results] Patients carrying rs2295080 GG genotype survived less than those with the TG/TF genotypes (HR=3.07,95％CI:1.15～8.22) in the colon cancer subgroup.This risk effect was more remarkable among patients with moderately differentiated cancers,no lymph node metastasis,and TNM stage Ⅱ.For rectal cancer patients,rs2295080 TG/GG genotypes had better prognosis compared with the TI genotype (HR=0.48,95％CI:0.23～0.99).This risk effect was more remarkable among patients with no distant metastasis and TNM stage Ⅲ.[Conclusions] SNP rs2295080 may be related to the survival of colorectal cancer patients and can be a potential prognostic biomarker of colorectal cancer.

Polymorphism in mTOR (rs2295080) and Its Association with Survival of Colorectal Cancer Patients